OP08 High dose (HD-AraC) vs standard dose cytosine arabinoside (SD-AraC) during induction in acute myelogenous leukemia (AML): Impact on stem cell mobilization after consolidation and on autologous transplantation (AML-12 trial)

Authors :: Franco Mandelli
D Selleslag
Georges Fillet
JP Marie
Vincenzo Liso
Boris Labar
Meral Beksac
Stefan Suciu
Paola Fazi
Liliana Baila
M. Mistrik
D Bron
P. Muus
Antonio Peta
Francesco Fabbiano
R. Willemze
Marco Vignetti
Xavier Thomas
A. Theys
T. de Witte
Giovanna Meloni
S. Amadori
Source :: Leukemia Research. 31:S34-S35
Publication Year :: 2007
Publisher :: Elsevier BV, 2007.

Subjects :: Cancer Research
Acute myelogenous leukemia (AML)
business.industry
Stem cell mobilization
Hematology
medicine.disease
chemistry.chemical_compound
Oncology
chemistry
Cancer research
Medicine
Autologous transplantation
business
Cytosine

Tools